Radkhah, H., Rahimipour Anaraki, S., Parhizkar Roudsari, P., Arabzadeh Bahri, R., Zooravar, D., Asgarian, S., . . . Khalooeifard, R. (2025). The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 30(1), . https://doi.org/10.1007/s40519-025-01720-9
Chicago-referens (17:e uppl.)Radkhah, Hanieh, Shiva Rahimipour Anaraki, Peyvand Parhizkar Roudsari, Razman Arabzadeh Bahri, Diar Zooravar, Sara Asgarian, Reza Hosseini Dolama, Ali Alirezaei, och Razieh Khalooeifard. "The Impact of Glucagon-like Peptide-1 (GLP-1) Agonists in the Treatment of Eating Disorders." Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 30, no. 1 (2025). https://doi.org/10.1007/s40519-025-01720-9.
MLA-referens (9:e uppl.)Radkhah, Hanieh, et al. "The Impact of Glucagon-like Peptide-1 (GLP-1) Agonists in the Treatment of Eating Disorders." Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, vol. 30, no. 1, 2025, https://doi.org/10.1007/s40519-025-01720-9.
